Shire said to be participating in Merrimack Pharmaceuticals "strategic review" - sources
Friday, 11 November 2016, 12:33 am
Reuters landed a good story earlier this week about a US biopharmaceutical company called Merrimack Pharmaceuticals carrying out a "strategic review" (banker parlance for a sale or sale of assets). Here is a link to the Reuters piece:
http://www.reuters.com/article/us-merrimack-pharma-m-a-idUSKBN1342QZ..